Alcântara, L.M.; Ferreira, T.C.S.; Fontana, V.; Chatelain, E.; Moraes, C.B.; Freitas-Junior, L.H.
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules 2020, 25, 2551.
https://doi.org/10.3390/molecules25112551
AMA Style
Alcântara LM, Ferreira TCS, Fontana V, Chatelain E, Moraes CB, Freitas-Junior LH.
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules. 2020; 25(11):2551.
https://doi.org/10.3390/molecules25112551
Chicago/Turabian Style
Alcântara, Laura M., Thalita C. S. Ferreira, Vanessa Fontana, Eric Chatelain, Carolina B. Moraes, and Lucio H. Freitas-Junior.
2020. "A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity" Molecules 25, no. 11: 2551.
https://doi.org/10.3390/molecules25112551
APA Style
Alcântara, L. M., Ferreira, T. C. S., Fontana, V., Chatelain, E., Moraes, C. B., & Freitas-Junior, L. H.
(2020). A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules, 25(11), 2551.
https://doi.org/10.3390/molecules25112551